SIT AND DELIVER

Crossing The Blood-Brain Barrier To Target Tumors With CNS Pharmaceuticals
Targeting glioblastoma (GBM) and other malignant brain tumors brings with it the long-standing challenge of crossing the blood-brain barrier, or BBB. In this episode of Sit and Deliver, host Tom von Gunden talks with CEO John Climaco and Chief Medical Officer Dr....
ABOUT SIT AND DELIVER
Created for stakeholders across the drug delivery landscape, from sponsor companies to regulatory agencies, Sit and Deliver offers timely insights from leading thinkers on drug delivery trends, movements, opportunities, and challenges.
MEET YOUR HOST

On each episode of Sit and Deliver, Drug Delivery Leader Chief Editor Tom von Gunden frames a topic of interest and impact to drug delivery professionals and invites a guest commentator to “deliver” perspectives on that focused topic.
Interested in joining Tom on an episode? Contact him today.